Usana Health Sciences (USNA) Invested Capital (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of Invested Capital data on file, last reported at $557.6 million in Q2 2026.

• Invested Capital for Q2 2026 came in at $557.6 million, up 0.87% year-over-year; the trailing twelve-month figure through Apr 2026 was $557.6 million (up 0.87% YoY), and the FY2026 annual result was $547.1 million, down 1.44% from the prior year.
• Invested Capital rose to $557.6 million in Q2 2026 per USNA's latest filing, from $547.1 million in the prior quarter.
• Over five years, Invested Capital peaked at $557.6 million in Q2 2026 and troughed at $395.1 million in Q1 2022.
• A 5-year average of $486.4 million and a median of $499.6 million in 2023 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2022 and 2023: Invested Capital decreased 10.53% in 2022, then climbed 16.14% in 2023.
• A 5-year view of Invested Capital shows it stood at $434.5 million in 2022, then grew by 14.62% to $498.0 million in 2023, then advanced by 11.47% to $555.1 million in 2024, then fell by 4.87% to $528.1 million in 2025, then rose by 5.58% to $557.6 million in 2026.
• Business Quant data shows USNA's Invested Capital at $557.6 million in Q2 2026, $547.1 million in Q1 2026, and $528.1 million in Q3 2025.